Energy Fuels (EFR) Q3 2025 earnings summary

Executive summary

• Revenues for Q3 2025 rose 338% year-over-year to $17.7 million, driven by higher uranium sales volumes, with continued low-cost uranium mining and strong cash margins, positioning for higher gross margins in 2026.

• Advanced critical minerals strategy by ramping up uranium mining, expanding rare earth element (REE) separation at White Mesa Mill, and progressing heavy mineral sands (HMS) projects in Madagascar, Australia, and Brazil.

• Completed a $700 million convertible note offering in October 2025, boosting working capital to nearly $1 billion and funding REE initiatives and general corporate purposes.

• Secured all government approvals and conditional support for up to AUD 80 million in project financing for the Donald JV project in Australia.

• NdPr oxide validated by major manufacturers, supporting rare earth segment growth and commercial production plans for Dy and Tb oxides in 2026.

Financial highlights

• Q3 2025 revenues reached $17.7 million, up from $4.0 million in Q3 2024; working capital at September 30, 2025, was $298.5 million, with $94.0 million in cash and marketable securities totaling $235.3 million.

• Net loss improved to $16.7 million from $21.8 million in the previous quarter, but was higher year-over-year due to increased operating costs post-acquisition.

• Sold 240,000 lbs of uranium at $72.38/lb with a 26% gross margin in Q3; similar margins expected in Q4.

• Operating costs for Q3 2025 were $44.4 million, up 178% year-over-year.

• Total assets increased 24% year-over-year to $758.3 million; total liabilities decreased 37% to $50.8 million.

Outlook and guidance

• Uranium production expected to reach 875,000–1,435,000 lbs in 2025, with finished uranium inventory at year-end projected at 925,000–1,225,000 lbs.

• Finished uranium costs expected to decline to $23–$30/lb for new production, with blended costs dropping to $30–$40/lb in Q1 2026 and gross margins rising to 50% or above.

• Rare earth commercial production of Dy and Tb oxides targeted for late 2026; phase II feasibility study at White Mesa Mill to be completed by year-end.

• Donald Project FID expected as early as Q4 2025 or Q1 2026, with monazite deliveries by late 2027.

• Toliara Project FID anticipated in 2026, with ongoing feasibility and permitting.